Brixton Biosciences Nabs $33M to Advance Novel Pain Therapies
Brixton Biosciences, a clinical-stage life sciences company focused on innovative pain treatments raises $33M in Series B funding led by...
Source: hitconsultant.net
Stay updated with breaking news from Neural Ice. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Brixton Biosciences, a clinical-stage life sciences company focused on innovative pain treatments raises $33M in Series B funding led by...